Infinimmune vs Sinopia Biosciences
Infinimmune vs Sinopia Biosciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Infinimmune is on 60/100 and Sinopia Biosciences on 54/100.
Where each one leads
Infinimmune
- our overall score: 60/100 against 54/100
- domain rating: 20/100 against 10/100
- funding raised: $75.0M against $2.2M
Sinopia Biosciences
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Infinimmune | Sinopia Biosciences |
|---|---|---|
| What it is | Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms. | Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech | Biotechnology, Drug Discovery, Oncology, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2017 |
| Headquarters | Alameda, United States | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Infinimmune | Sinopia Biosciences |
|---|---|---|
| Employees | 22 | Not published |
| Total funding | $75.0M | $2.2M |
| Latest round | Series A | Grant |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 4,055 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Infinimmune | Sinopia Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 54/100 |
| Traction | 53/100 | 32/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 23/100 | 15/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 10/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Infinimmune | Sinopia Biosciences |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | Squarespace |
| Analytics | Google Analytics 4 | Not detected |
Infinimmune vs Sinopia Biosciences: common questions
Which is better, Infinimmune or Sinopia Biosciences?
On our 0-100 score Infinimmune rates higher (60/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Infinimmune and Sinopia Biosciences compare on the numbers?
Infinimmune leads on our overall score (60/100 against 54/100), domain rating (20/100 against 10/100), funding raised ($75.0M against $2.2M).
Read the full Infinimmune review and pricing or the Sinopia Biosciences review and pricing. You can also browse other Infinimmune alternatives we track.